Company Name: |
Shanghai Yiyan Biotechnology Co. , Ltd.
|
Tel: |
021-69985186 13611928337 |
Email: |
3427709316@qq.com |
Products Intro: |
Product Name:Hepatitis A Virus Cellular Receptor 1 Package:48T/RMB 1200;96T/RMB 1800
|
|
Product Name: | TIMD1 | Synonyms: | Hepatitis A virus cellular receptor 1;KIM1;T-cell immunoglobulin and mucin domain-containing protein 1;T-cell immunoglobulin and mucin domain-containing protein 4;Tim-1 (human): FC (human);TIMD1;IL-35 (mouse): FC (human);Interleukin-35 | CAS: | | MF: | | MW: | 0 | EINECS: | | Product Categories: | Elisa Kit-Mouse Elisa Kit | Mol File: | Mol File | |
| TIMD1 Chemical Properties |
storage temp. | -20°C | form | lyophilized | color | white | biological source | human mouse |
| TIMD1 Usage And Synthesis |
Uses | IL-35 has been used to study its immunosuppressive effect on acute graft-versus-host disease in a mouse model.Ithas also been used to study its effects on the differentiation of granulocytemacrophage-colony-stimulating factor-producing T helper cells (ThGM). IL-35has been used to study its effects on bleomycin-induced pulmonary fibrosis. | Biological Activity | Regulatory T cells are essential for maintaining self tolerance and preventing autoimmunity, and IL-35 is identified as a molecule th at mediates the immune suppression function of Treg-cell. As an inhibitory cytokine, IL-35 induces proliferation of Treg-cell populations but suppresses Th17 cell development. Studies in mice show the absence of either IL-35 chain from Treg-cell reduces the cellsμ ability to suppress inflammation using an experimental model for inflammatory bowel disease. IL-35 is suggested as a potential target of immunotherapy.IL-35 is produced inresponse to agonists of toll-like receptors 3 and 4 (TLR 3 & 4) and interferon γ (IFN-γ). It is secreted mainly by activated B cells, CD4+ Foxp3+ regulatoryT cells (Tregs), and at a lower concentration by monocytes, smooth muscle cells, and endothelial cells. |
| TIMD1 Preparation Products And Raw materials |
|